Showing 1971-1980 of 20420 results for "".
Managing Immune-Related Adverse Events in Cervical and Endometrial Cancer
https://reachmd.com/programs/cme/Managing-Immune-Related-Adverse-Events-in-Cervical-and-Endometrial-Cancer/39296/Multidisciplinary experts explore biomarker-driven strategies, immunotherapy, and personalized care in cervical and endometrial cancer management.Practical Strategies for Improving Patient Adherence with Topical Regimens
https://reachmd.com/videos/dermatology-hub-neuroimmune-network/practical-strategies-for-improving-patient-adherence-with-topical-regimens/39707/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, describes tactics involving topical therapeutics to improve patient adherence with atopic dermatitis.Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
https://reachmd.com/programs/neurofrontiers/genetic-pathways-in-ms-the-clinical-impact-of-a-chromosome-2-variant/32820/In a landmark study involving over 10,000 patients, the International MS Genetics Consortium (IMSGC) has identified the first genetic variant associated with disease severity in multiple sclerosis (MS). Dr. Sergio Baranzini, a Distinguished Professor of Neurology at the University of CalifornNavigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
https://reachmd.com/programs/clinicians-roundtable/navigating-treatment-goals-in-igan-the-impact-of-et-1-and-ang-ii/37214/Given that the endothelin-1 (ET-1) and angiotensin II (Ang II) pathways contribute to the pathogenesis of IgA nephropathy (IgAN), it’s important to set treatment goals that prevent disease progression. Joining Dr. Charles Turck to discuss the role and impacts of ET-1 and Ang II and how we can achievIncreased APS Risk for Psoriasis Patients, Plus More
https://reachmd.com/videos/dermwire-tv/increased-aps-risk-for-psoriasis-patients-plus-more/39299/This episode highlights research showing increased risk for anti-phospholipid syndrome (APS) in patients with psoriatic disease, as well as research showing increased risks for tuberculosis in patients treated with immunosuppressants. The episode also features a clip from an in-depth discussion arouEquitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
https://reachmd.com/programs/heart-matters/equitable-care-for-attr-cm-improving-early-diagnosis-in-high-risk-groups/36142/Early detection of transthyretin amyloid cardiomyopathy (ATTR-CM), particularly in high-risk populations, requires a multifaceted approach that combines community-based interventions, collaboration across specialties, and technological integration. Join Dr. Kevin Alexander, an Assistant Professor ofImproving Postoperative Wound Outcomes Through Patient-Centered Education and Systemic Tools
https://reachmd.com/programs/clinicians-roundtable/improving-postoperative-wound-outcomes-through-patient-centered-education-and-systemic-tools/35839/Gaps in patient education and care coordination after surgery often hinder postoperative wound recovery. Join Dr. Karen Bauer as she discusses the importance of health literacy, access, and evidence-based care algorithms in engaging patients and support systems across the continuum. Dr. Bauer is a cFDA Grants Interchangeability to HADLIMA
https://reachmd.com/videos/dermwire-tv/fda-grants-interchangeability-to-hadlima/35962/In this week's DermwireTV, the FDA grants full interchangeability to HADLIMA; new research shows the impact of UV exposure on global skin cancer cases; and coverage from Music City SCALE addresses barriers to patient access to new therapies.Improving Conduit and Neobladder Efficiency: Surgical and Post-Operative Strategies
https://reachmd.com/programs/clinicians-roundtable/Improving-conduit-and-neobladder-efficiency-surgical-and-post-operative-strategies/33038/Optimizing urinary diversion and continence techniques is essential for improving patient outcomes and quality of life following surgery. Join Dr. Mutahar Ahmed as he provides expert guidance on improving success in conduits and neobladders in the operating room and beyond. Dr. Ahmed is the DirectorImproving the Detection and Prevention of PPD: The Potential Role of Biomarkers
https://reachmd.com/programs/advances-in-womens-health/improving-the-detection-and-prevention-of-ppd-the-potential-role-of-biomarkers/32754/Only about 3 percent of women with postpartum depression (PPD) get treated all the way to remission, underscoring the importance of identifying and preventing this mental health condition. Based on a recent study, levels of progesterone might be an effective predictive biomarker, which could help id